![Julio Castro-Palomino Laria](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Julio Castro-Palomino Laria
Oprichter bij Origo Biopharma SL
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Maria do Carme Pampín Casal | M | - |
Origo Biopharma SL
![]() Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | 7 jaar |
Ramon Bosser | M | - |
Origo Biopharma SL
![]() Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | - |
Andrea Sáez | M | - |
Origo Biopharma SL
![]() Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | - |
Clara Campas-Moya | M | - |
Origo Biopharma SL
![]() Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | - |
Yolanda Falcón | F | - |
Origo Biopharma SL
![]() Origo Biopharma SL BiotechnologyHealth Technology Part of AgomAb Therapeutics NV, Origo Biopharma SL engages in research and development of immunotherapeutic products which are focused on treating health disorders. The company is based in A Coruña, Spain. The Spanish company was founded in 2017 by Maria do Carme Pampín Casal, Julio Castro-Palomino Laria. The CEO is Ramon Bosser. Origo Biopharma was acquired by AgomAb Therapeutics NV on December 15, 2021. | - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Spanje | 5 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Julio Castro-Palomino Laria
- Persoonlijk netwerk